Nittaya Phanuphak Selected Research

Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)

1/2017

Persistent, Albeit Reduced, Chronic Inflammation in Persons Starting Antiretroviral Therapy in Acute HIV Infection.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Nittaya Phanuphak Research Topics

Disease

45	HIV Infections (HIV Infection) 04/2024 - 10/2008
35	Infections 11/2023 - 02/2004
9	Sexually Transmitted Diseases (Sexually Transmitted Disease) 09/2023 - 09/2003
9	Inflammation (Inflammations) 01/2023 - 01/2016
5	Viremia 01/2023 - 01/2016
5	Syphilis 01/2022 - 01/2018
4	Hepatitis C 01/2022 - 01/2020
3	Papillomavirus Infections 11/2023 - 01/2020
3	Immune Reconstitution Inflammatory Syndrome 11/2022 - 01/2020
3	Disease Progression 10/2022 - 01/2016
3	Tuberculosis (Tuberculoses) 08/2012 - 02/2010
2	Squamous Intraepithelial Lesions 05/2024 - 01/2013
2	Persistent Infection 11/2023 - 01/2018
2	COVID-19 01/2022 - 10/2021
2	Acquired Immunodeficiency Syndrome (AIDS) 01/2017 - 01/2017
1	Neuroinflammatory Diseases 01/2024
1	Leukocytosis (Pleocytosis) 11/2023
1	Gender Dysphoria 11/2022
1	Virus Diseases (Viral Diseases) 01/2022
1	Hepatitis B 01/2022
1	Injection Site Reaction 12/2021
1	Liver Cirrhosis (Hepatic Cirrhosis) 06/2021
1	Lymphopenia (Lymphocytopenia) 01/2021
1	Anus Neoplasms (Anal Cancer) 01/2021
1	Neoplasms (Cancer) 01/2021
1	Dysbiosis 12/2020
1	Vaccinia 01/2020
1	Coinfection 01/2019
1	Bacterial Vaginosis 11/2018
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2018
1	HIV Seropositivity 01/2018
1	Acute-Phase Reaction 01/2017
1	Fibrosis (Cirrhosis) 01/2017

Drug/Important Bio-Agent (IBA)

17	RNA (Ribonucleic Acid)IBA 11/2023 - 02/2004
11	Biomarkers (Surrogate Marker)IBA 09/2023 - 01/2013
7	DNA (Deoxyribonucleic Acid)IBA 01/2023 - 01/2013
6	Nucleic AcidsIBA 01/2021 - 10/2008
5	VaccinesIBA 11/2023 - 10/2008
4	AntigensIBA 01/2022 - 04/2015
4	Amphetamine (Amfetamine)FDA LinkGeneric 01/2020 - 12/2017
3	Antiviral Agents (Antivirals)IBA 04/2024 - 01/2020
3	Methamphetamine (Desoxyn)FDA LinkGeneric 01/2021 - 01/2020
3	Integrase InhibitorsIBA 01/2020 - 01/2015
3	Isoniazid (Ftivazide)FDA LinkGeneric 08/2012 - 02/2010
2	dolutegravirIBA 01/2023 - 01/2019
2	Viral RNAIBA 01/2023 - 11/2021
2	HLA Antigens (Human Leukocyte Antigens)IBA 01/2023 - 10/2022
2	C-Reactive ProteinIBA 01/2023 - 01/2017
2	EpitopesIBA 10/2022 - 01/2021
2	cabotegravirIBA 12/2021 - 11/2021
2	Emtricitabine (Emtriva)FDA Link 12/2021 - 01/2018
2	RacivirIBA 12/2021 - 11/2021
2	Tenofovir (Viread)FDA Link 12/2021 - 01/2018
2	IntegrinsIBA 12/2020 - 01/2018
2	AntibodiesIBA 01/2020 - 01/2016
2	EnzymesIBA 01/2019 - 10/2008
2	Monoclonal AntibodiesIBA 01/2019 - 01/2018
2	N-acetyltalosaminuronic acid (NAT)IBA 04/2015 - 10/2008
2	Tuberculin (PPD)IBA 08/2012 - 03/2012
1	Papillomavirus Vaccines (HPV Vaccines)IBA 11/2023
1	efavirenz (Sustiva)FDA Link 01/2023
1	Biological FactorsIBA 01/2023
1	Hormones (Hormone)IBA 11/2022
1	Hepatitis B Surface Antigens (HBsAg)FDA Link 01/2022
1	CreatinineIBA 01/2022
1	Alanine Transaminase (SGPT)IBA 01/2022
1	IntegrasesIBA 12/2021
1	ReaginsIBA 01/2021
1	Chemokine ReceptorsIBA 12/2020
1	Ribosomal DNA (rDNA)IBA 12/2020
1	Histone Deacetylase InhibitorsIBA 09/2020
1	Vorinostat FDA Link 09/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Indicators and Reagents (Reagents)IBA 01/2020
1	NucleosidesIBA 01/2020
1	Reverse Transcriptase InhibitorsIBA 01/2020
1	Combined VaccinesIBA 01/2020
1	Protease Inhibitors (Protease Inhibitor)IBA 01/2020
1	ChemokinesIBA 01/2018
1	Lipopolysaccharide ReceptorsIBA 01/2017
1	fibrin fragment D (D-dimer)IBA 01/2017
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2017
1	Cytokine Receptor gp130IBA 01/2017
1	LipopolysaccharidesIBA 01/2017
1	Fatty Acid-Binding ProteinsIBA 01/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	Hemoglobins (Hemoglobin)IBA 01/2017
1	HIV AntigensIBA 01/2017

Therapy/Procedure

34	Therapeutics 05/2024 - 09/2003
23	Art Therapy 04/2024 - 12/2014
6	Highly Active Antiretroviral Therapy (HAART) 01/2024 - 02/2004
4	Aftercare (After-Treatment) 10/2020 - 01/2015
2	Injections 12/2021 - 11/2021
1	Continuity of Patient Care 01/2022
1	Ambulatory Care (Outpatient Care) 01/2021
1	Secondary Prevention 11/2020
1	Copper Intrauterine Devices 11/2018
1	Condoms (Condom) 12/2017